| Literature DB >> 26275616 |
Laura C Clark1, Jonathan Hodgkin1.
Abstract
Three Gram-stain-positive, irregular-rod-shaped, non-motile, non-spore-forming bacteria were isolated from nematodes collected from Santa Antao, Cabo Verde (CBX151T, CBX152T) and Kakegawa, Japan (CBX130T). Based on 16S rRNA gene sequence similarity, strains CBX130T, CBX151T and CBX152T were shown to belong to the genus Leucobacter. This affiliation was supported by chemotaxonomic data (2,4-diaminobutyric acid in the cell wall; major respiratory quinones MK-10 and MK-11; major polar lipids phosphatidylglycerol and diphosphatidylglycerol; major fatty acids anteiso-C15 : 0, anteiso-C17 : 0 and iso-C16 : 0). Strains CBX130T and CBX152T were found to share salient characteristics. Based on morphological, physiological, chemotaxonomic and biochemical analysis, strain CBX152T represents a novel species of the genus Leucobacter, for which the name Leucobacter musarum sp. nov. (type strain CBX152T = DSM 27160T = CIP 110721T) is proposed. Two subspecies of Leucobacter musarum sp. nov. are proposed: Leucobacter musarum sp. nov. subsp. musarum subsp. nov. (type strain CBX152T = DSM 27160T = CIP 110721T) and Leucobacter musarum sp. nov. subsp. japonicus subsp. nov. (type strain CBX130T = DSM 27158T = CIP 110719T). The third novel strain, CBX151T, showed genetic similarities with Leucobacter celer NAL101T indicating that these strains belong to the same species. Based on morphological, physiological, chemotaxonomic and biochemical differences it is proposed to split the species Leucobacter celer into two novel subspecies, Leucobacter celer subsp. celer subsp. nov. (type strain NAL101T = KACC 14220T = JCM 16465T) and Leucobacter celer subsp. astrifaciens subsp. nov. (type strain CBX151T = DSM 27159T = CIP 110720T), and to emend the description of Leucobacter celerShin et al. 2011.Entities:
Mesh:
Substances:
Year: 2015 PMID: 26275616 PMCID: PMC4804768 DOI: 10.1099/ijsem.0.000523
Source DB: PubMed Journal: Int J Syst Evol Microbiol ISSN: 1466-5026 Impact factor: 2.747
Fig. 1.Leucobacter 16S rRNA gene maximum-likelihood bootstrap consensus tree. The evolutionary history was inferred by using the maximum-likelihood method based on the Tamura-Nei model. The bootstrap consensus tree inferred from 1000 replicates is taken to represent the evolutionary history of the taxa analysed. Branches corresponding to partitions reproduced in less than 50 % bootstrap replicates are collapsed. Initial tree(s) for the heuristic search were obtained by applying the neighbour-joining method to a matrix of pairwise distances estimated using the Maximum Composite Likelihood (MCL) approach. The analysis involved 21 nt sequences. All positions containing gaps and missing data were eliminated. There were 1376 positions in the final dataset. Evolutionary analyses were conducted in mega6.
Physiological characteristics of type strains of selected species of the genus Leucobacter
Strains: 1, CBX130T; 2, CBX152T; 3, CBX151T; 4, L. celer DSM 26651T; 5, L. chromiiresistens DSM 22788T; 6, L. komagatae DSM 8803T (type species for the genus). All strains were negative for acid production from erythritol, d-arabinose, l-arabinose, methyl β-d-xylopyranoside, d-galactose, dulcitol, d-sorbitol, methyl α-d-mannopyranoside, methyl α-d-glucopyranoside, N-acetylglucosamine, amygdalin, arbutin, salicin, maltose, lactose, melibiose, sucrose, inulin, melezitose, raffinose, starch, glycogen, gentiobiose, turanose, d-fucose, l-fucose, d-arabitol, l-arabitol, potassium gluconate and potassium 2-ketogluconate. All strains were also negative for assimilation of l-arabinose, capric acid, adipic acid and phenylacetic acid, and activity of urease, arginine dihydrolase, β-galactosidase and β-glucosidase. All strains grew in the presence of apramycin (50 μg ml− 1) and nalidixic acid (50 μg ml− 1), and were sensitive to ampicillin (50 μg ml− 1), carbenicillin (100 μg ml− 1), penicillin G (100 μg ml− 1) and streptomycin (50 μg ml− 1). Experiments were performed at least twice and representative results are shown. Results for L. komagatae DSM 8803T, L. chromiiresistenss DSM 22788T and L. celer DSM 26651Twere consistent with those reported by Takeuchi , Sturm and Shin except: L. komagatae DSM 8803T was negative for acid production from d-adonitol; L. chromiiresistens DSM 22788T was positive for acid production from glycerol, d-ribose, l-rhamnose, trehalose, xylitol, d-lyxose and potassium 5-ketogluconate. These inconsistencies are likely due to a longer incubation than that used by Sturm ; indeed, the results we observed at the earlier 120 h time point were consistent with theirs. +, Positive, − , negative; (+), weakly positive; na, not applicable; nd, data not available.
| Characteristic | 1 | 2 | 3 | 4 | 5 | 6 |
|---|---|---|---|---|---|---|
| Growth in presence of (μg ml− 1): | ||||||
| Kanamycin (50) | (+) | (+) | + | + | + | |
| Gentamicin (15) | − | (+) | (+) | + | − | |
| Erythromycin (20) | − | − | (+) | − | − | |
| Tetracycline (15) | − | (+) | (+) | + | + | − |
| Chloramphenicol (25) | − | − | − | − | (+) | (+) |
| Growth at 37 °C | − | − | + | + | + | − |
| Pigment production | ||||||
| Constitutive | (+) | + | − | − | + | − |
| On light exposure | + | + | − | |||
| Acid production from: | ||||||
| Glycerol | + | + | − | − | + | (+) |
| | − | − | + | (+) | (+) | (+) |
| | − | − | − | (+) | − | − |
| | − | − | − | + | − | − |
| | − | − | − | (+) | − | − |
| | − | − | − | + | − | − |
| | + | − | − | + | − | − |
| | − | − | − | (+) | − | − |
| | + | + | + | + | (+) | − |
| Inositol | − | − | + | + | − | − |
| | + | + | + | + | − | − |
| Aesculin | + | + | + | + | + | − |
| | − | − | − | + | − | − |
| | − | + | − | + | + | − |
| Xylitol | + | + | − | − | + | − |
| | − | (+) | − | + | (+) | − |
| | − | (+) | − | − | − | − |
| Potassium 5-ketogluconate | (+) | + | − | − | (+) | − |
| Activity | ||||||
| Protease (gelatin hydrolysis) | + | + | − | − | − | + |
| Oxidase reaction | − | − | + | − | − | − |
| Assimilation of: | ||||||
| | + | + | − | + | + | − |
| | + | + | − | + | − | − |
| | + | − | + | + | − | − |
| | − | − | − | + | − | − |
| | − | − | − | + | − | − |
| Potassium gluconate | + | − | + | + | − | − |
| Malic acid | (+) | + | − | − | + | − |
| Trisodium citrate | − | − | + | + | − | − |
| Respiratory quinones | ||||||
| Major | MK-11 | MK-10 | MK-11 | MK-11 | MK-11 | MK-11 |
| Minor | MK-10, MK-9 | MK-11, MK-9, MK-8 | MK-10, MK-9 | MK-9, MK-10 | MK-10, MK-9, MK-8 | MK-10, MK-12 |
| Fatty acids | aiC15 : 0, aiC17 : 0, iC16 : 0, C16 : 0 | aiC15 : 0, aiC17 : 0, iC16 : 0, C16 : 0 | aiC15 : 0, aiC17 : 0, iC16 : 0, iC15 : 0, iC17 : 0 | aiC15 : 0, aiC17 : 0, iC16 : 0, iC15 : 0 | aiC15 : 0, aiC17 : 0, iC16 : 0 | aiC15 : 0, aiC17 : 0, iC16 : 0 |
| Polar lipids | PG, DPG, GL, PL | PG, DPG, GL × 2, PL | PG, DPG, GL × 2 | PG, DPG, GL | PG, DPG, GL, PL | PG, DPG, GL |
| Peptidoglycan includes: | Ala, Gly, Glu, Thr | Ala, Gly, Glu, Thr | Ala, Gly, Glu, Thr | Ala, Gly, Glu, Thr | Ala, Gly, Glu, Thr | Ala, Gly, Glu |
| Diamino acid | DAB | DAB | DAB | DAB | DAB | DAB, GABA |
| Cross-link type | B | B | B | B | B | B |
| DNA G+C content (mol%) | 66.76 | 66.77 | 69.09 | 69.22 | 64.23 | 66 |
| Genome size (Mb) | 3.59 | 3.44 | 4.15 | 4.16 | 3.37 | |
PG, Phosphatidylglycerol; DPG, diphosphatidylglycerol; GL, unknown glycolipid; PL, unknown phospholipid.
DAB, Diaminobutyric acid; GABA, γ-aminobutryic acid.